Photo of Bonnie Chen

Bonnie Chen

Partner, Paul Weiss

212-373-3905bchen@paulweiss.com

1285 Avenue of the Americas
New York, NY 10019

View Firm Biography

Bonnie Chen is a partner in the Intellectual Property & Technology Transactions Group. Chen focuses her practice on advising clients on a wide range of IP and technology-related corporate and commercial transactions, including intellectual property aspects of public and private mergers, acquisitions, joint ventures, and carve-outs. She also advises on licensing and collaboration agreements, research and development agreements, supply agreements, distribution agreements and other strategic commercial agreements.

With a degree in biological engineering, Chen has extensive experience with advising clients in the pharmaceutical, biotechnology and medical device industries, including transactions involving small molecules, biologics, and gene therapies. Chen also has extensive experience with advising clients in the technology, media and telecommunications, financial institutions, retail and fashion industries.

Lawdragon Honors

Honor Year Practice
The 2026 Lawdragon 500 X – The Next Generation 2026 IP, Tech Transactions
The 2025 Lawdragon 500 X – The Next Generation 2025 IP, Tech Transactions
The 2024 Lawdragon 500 X – The Next Generation 2024 Corporate , Technology Transactions

Chen’s notable representations have included:

  • GSK in its acquisition of CMG1A46, an autoimmune disease treatment, from Chimagen Biosciences
  • Carrier Global Corporation in its:
    • $3 billion sale of its commercial and residential fire business to an affiliate of Lone Star Funds
    • €12 billion acquisition of Viessmann Climate Solution
    • $1.425 billion sale of its industrial fire business to Sentinel Capital Partners
  • Merck in its $10.8 billion acquisition of Prometheus Biosciences
  • Eli Lilly in:
    • its up to $8.5 billion strategic collaboration with Innovent Biologics, a regular collaborator with Lilly, to advance novel medicines in oncology and immunology
    • a strategic platform-based collaboration with Ailux, a wholly owned subsidiary of XtalPi, to advance bispecific antibody development
  • The Estée Lauder Companies in its $2.8 billion acquisition of the Tom Ford brand
  • Dana Incorporated in its approximately $2.7 billion sale of its off-highway business to Allison Transmission Holdings
  • Funds managed by affiliates of Apollo Global Management in:
    • an investment of $11 billion to acquire from Intel Corporation a 49% equity interest in a joint venture entity related to Intel’s Fab 34
    • their ¥311 billion investment (approximately $2.05 billion) to acquire a majority stake in Panasonic Automotive Systems Co.
  • Fernando Chico Pardo and his family in their $2.3 billion acquisition of a 25% equity stake in Grupo Financiero Banamex from Citi
  • Ashton Kutcher in his investment in Soho House & Co., in connection with Soho House’s $2.7 billion take-private transaction
  • Fernando Chico Pardo and his family in their $2.3 billion acquisition of a 25% equity stake in Grupo Financiero Banamex
  • 23andMe in voluntary chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri
  • Polaris in the separation of Indian Motorcycle and subsequent sale of a majority stake in the new company to Carolwood